Global Patent Index - EP 2125893 A2

EP 2125893 A2 20091202 - OPTIMIZED CD40 ANTIBODIES AND METHODS OF USING THE SAME

Title (en)

OPTIMIZED CD40 ANTIBODIES AND METHODS OF USING THE SAME

Title (de)

OPTIMIERTE CD40-ANTIKÖRPER UND ANWENDUNGSVERFAHREN DAFÜR

Title (fr)

ANTICORPS CD40 OPTIMISÉS ET LEURS PROCÉDÉS D'UTILISATION

Publication

EP 2125893 A2 20091202 (EN)

Application

EP 08728147 A 20080123

Priority

  • US 2008051812 W 20080123
  • US 88629107 P 20070123

Abstract (en)

[origin: WO2008091954A2] The present invention describes antibodies that target CD40, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an FcyR or alters effector function as compared to the parent antibody. Also disclosed are methods of using the antibodies of the invention.

IPC 8 full level

C07K 16/28 (2006.01)

CPC (source: EP)

A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); C07K 16/2878 (2013.01); C07K 2317/72 (2013.01); C07K 2317/73 (2013.01)

Citation (search report)

See references of WO 2008091954A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA MK RS

DOCDB simple family (publication)

WO 2008091954 A2 20080731; WO 2008091954 A3 20080904; WO 2008091954 A4 20081231; AU 2008207898 A1 20080731; AU 2008207898 B2 20120503; CA 2669412 A1 20080731; EP 2125893 A2 20091202; JP 2010514460 A 20100506; JP 5357778 B2 20131204

DOCDB simple family (application)

US 2008051812 W 20080123; AU 2008207898 A 20080123; CA 2669412 A 20080123; EP 08728147 A 20080123; JP 2009545016 A 20080123